Decompression sickness in extravehicular activities

Gravity and the Lung: Lessons from Microgravity

Volumn , Issue , 2001, Pages 289-333

  Norfleet, William T ^a   Butler, Bruce D ^b  

^a NASA HEADQUARTERS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84933281376     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (203)

1. Golding FC, Griffiths P, Hempleman HV, Paton WDM, Walder DN. Decompression sickness during construction of the Dartford Tunnel. Br J Ind Med 1960; 17: 167-180.
2. United States Navy. U.S. Navy Diving Manual. NAVSEA 0994-LP-9010. Washington, DC: Naval Sea Systems Command, 1993:22-26.
3. Weien RW. Transcribed comments. In: Pilmanis AA, ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base, TX: Air Force Systems Command. 1992:371.
4. United States Navy. U.S. Navy Diving Manual. NAVSEA 0994-LP-9010. Chapter 8. Washington. DC: Naval Sea Systems Command, 1993:66.
5. Francis TJR, Smith DJ, eds. Describing Decompression Illness. Proceedings of the 42nd Workshop of the Undersea and Hyperbaric Medical Society. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1991.
6. Wirjosemito SA, Touhey JE, Workman WT. Type II altitude decompression sickness (DCS): U.S. Air Force experience with 133 cases. Aviat Space Environ Med 1989; 60:256-262.
7. Dutka AJ. Clinical findings in decompression illness: A proposed terminology. In: Moon RE. Sheffield PJ, eds. Treatment of Decompression Illness. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996:1-9.
8. Zheng Q, Durben DJ, Wolf GH, Angell CA. Liquids at large negative pressures: Water at the homogeneous nucleation limit. Science 1991; 254:829-832.
9. Weathersby PK, Homer LD, Flynn ET. Homogeneous nucleation of gas bubbles in vivo. J Appl Physiol 1982; 53:940-946.
10. Eckenhoff RG, Osborne SF, Parker JW, Bondi KR. Direct ascent from shallow air saturation exposures. Undersea Biomed Res 1986; 13:305-316.
11. Dixon GA, Krutz R. Evaluation of 9.5 psia as a suit pressure for prolonged extravehicular activity. Proceedings of 23rd Annual Survival and Flight Equipment Symposium. Las Vegas, NV, 1985:122-123.
12. Vann RD, Grimstad J. Nielsen CH. Evidence for gas nuclei in decompressed rats. Undersea Biomed Res 1980; 7:107-112.
13. Evans A, Walder DN. Significance of gas micronuclei in the aetiology of decompression sickness. Nature 1969: 222:251-252.
14. McDonough PM, Hemmingsen EA. Bubble formation in crustaceans following decompression from hyperbaric gas exposures. J Appl Physiol 1984; 56:513-519.
15. McDonough PM. Hemmingsen EA. A direct test for the survival of gaseous nuclei in vivo. Aviat Space Environ Med 1985; 56:54-56.
16. Hemmingsen EA. Bubble formation mechanisms. In: Vann RD, ed. The Physiological Basis of Decompression. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1989:153-169.
17. Hayward ATJ. Tribonuclcation of bubbles. Br J Appl Physiol 1967; 18:641-644.
18. McDonough PM, Hemmingsen EA. Bubble formation in crabs induced by limb motions after decompression. J Appl Physiol 1984; 57:117-122.
19. McDonough PM. Hemmingsen EA. Swimming movements initiate bubble formation in fish decompressed from elevated gas pressures. Comp Biochem Physiol A 1985; 81:209-212.
20. Okang GI, Vann RD. Bubble formation in blood and urine. In: Vann RD. ed. The physiological basis of decompression. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1989:177-178.
21. Bayne CG. Hunt WS. Johnson DC. Flynn ET. Weathersby PK. Doppler bubble detection and decompression sickness: A prospective clinical trial. Undersea Bio-med Res 1985; 12:327-332.
22. Conkin J, Foster PP, Powell MR, Waligora JM. Relationship of the time course of venous gas bubbles to altitude decompression illness. Undersea Hyperb Med 1996; 23:141-149.
23. Nishi RY. Doppler and ultrasonic bubble detection. In: Bennett PB, Elliot DH, eds. The Physiology and Medicine of Diving. London: Saunders, 1993:433-453.
24. Eatock BC, Nishi RY. Analysis of Doppler ultrasonic data for the evaluation of dive profiles. In: Bove AA, Bachrach AJ, Greenbaum LJ, eds. Proceedings of 9th International Symposium on Underwater and Hyperbaric Physiology. Bethesda, MD: Undersea and Hyperbaric Medicine Society, 1987:183-195.
25. Herruningsen BB, Steinberg NA, Hemmingsen EA. Intracellular gas supersaturation tolerances of erythrocytes and resealed ghosts. Biophys J 1985; 47:491-496.
26. Hemmingsen EA, Hemmingsen BB. Bubble formation properties of hydrophobic particles in water and cells of Tetrahymena. Undersea Biomed Res 1990; 17:67-78.
27. Hills BA, James PB. Spinal decompression sickness: Mechanical studies and a model. Undersea Biomed Res 1982; 9:185-201.
28. Powell MR. Spencer MP. The Pathophysiology of Decompression Sickness and the Effects of Doppler Detectable Bubbles. Technical Report on ONR Contract N00014-73-C-0094. Seattle, WA: Institute of Applied Physiology and Medicine, 1980.
29. Gersh I, Catchpole HR. Appearance and distribution of gas bubbles in rabbits decompressed to altitude. J Cell Comp Physiol 1946; 28:253-268.
30. Chryssanthou C, Palaia T, Goldstein G, Stenger R. Increase in blood-brain barrier permeability by altitude decompression. Aviat Space Environ Med 1987; 58:1082-1086.
31. Ferris EB, Engel GL. The clinical nature of high altitude decompression sickness. In: Fulton JF, ed. Decompression Sickness. Philadelphia: Saunders, 1951:4-52.
32. Inman VT. Saunders JB. Referred pain from skeletal structures. J Nerv Ment Dis 1944; 99:660-667.
33. Vann RD. Vacuum phenomena: An anotated bibliography. In: Vann RD, ed. The Physiological Basis of Decompression. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1989:179-195.
34. Behnke AR. Decompression sickness following exposure to high pressures. In: Fulton JF, ed. Decompression Sickness. Philadelphia: Saunders, 1951:53-89.
35. Bateman JB. Preoxygenation and nitrogen elimination. In: Fulton JF, ed. Decompression Sickness. Philadelphia: Saunders, 1951:242-277.
36. Bason R. Altitude chamber DCS: USN experience 1981-1988. In: Pilmanis AA, ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base, TX: Air Force Systems Command, 1992: 395-413.
37. Lee WH. Jr. Hairston P. Structural effects on blood proteins at the gas-blood interface. Fed Proc 1971; 30:1615-1622.
38. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304:497-503.
39. Ward CA, Koheil A, McCullough D, Johnson WR, Fraser WD. Activation of complement at plasma-air or serum-air interface of rabbits. J Appl Physiol 1986; 60: 1651-1658.
40. Philp RB, Inwood MJ, Warren BA. Interactions between gas bubbles and components of the blood: Implications in decompression sickness. Aerosp Med 1972; 43: 946-953.
41. Bove AA. The basis for drug therapy in decompression sickness. Undersea Biomed Res 1982; 9:91-111.
42. Philp RB, Ackles KN, Inwood MJ, et al. Changes in the hemostatic system and in blood and urine chemistry of human subjects following decompression from a hyperbaric environment. Aerosp Med 1972; 43:498-505.
43. Thorsen T, Lie RT, Holmsen H. Induction of platelet aggregation in vitro by microbubbles of nitrogen. Undersea Biomed Res 1989; 16:453-464.
44. Albertine KH. Wiener-Kronish JP, Koike K, Staub NC. Quantification of damage by air emboli to lung microvessels in anesthetized sheep. J Appl Physiol 1984; 57: 1360-1368.
45. Moosavi H, Utell MJ, Hyde RW, et al. Lung ultrastructure in noncardiogenic pulmonary edema induced by air embolization in dogs. Lab Invest 1981; 45:456-464.
46. Staub NC, Schultz EL, Albertine KH. Leucocytes and pulmonary microvascular injury. Ann NY Acad Sci 1982; 384:332-343.
47. Benestad HB, Hersleth IB, Hardersen H, Molvaer OI. Functional capacity of neutrophil granulocytes in deep-sea divers. Scand J Clin Lab Invest 1990; 50:9-18.
48. Rothe G, Kellermann W, Valet G. Flow cytometric parameters of neutrophil function as early indicators of sepsis- or trauma-related pulmonary or cardiovascular organ failure. J Lab Clin Med 1990; 115:52-61.
49. Worthen GS, Schwab Bd, Elson EL, Downey GP. Mechanics of stimulated neutrophils: Cell stiffening induces retention in capillaries. Science 1989; 245:183-186.
50. Doerr TA, Rosolia DL, Peters SP, Gee MH, Albertine KH. PGE1 inhibited PMN attachment to air emboli in vivo during infusion of ZAP without preventing lung injury. J Appl Physiol 1992; 72:340-351.
51. Kindt GC, Gadek JE, Weiland JE. Initial recruitment of neutrophils to alveolar structures in acute lung injury. J Appl Physiol 1991; 70:1575-1585.
52. Wang D, Li MH, Hsu K, Shen CY, Chen HI, Lin YC. Air embolism-induced lung injury in isolated rat lungs. J Appl Physiol 1992; 72:1235-1242.
53. Flick MR, Perel A, Staub NC. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ Res 1981; 48:344-351.
54. Rick MR, Hoeffel JM, Staub NC. Superoxide dismutase with heparin prevents increased lung vascular permeability during air emboli in sheep. J Appl Physiol 1983; 55:1284-1291.
55. Binder AS, Nakahara K, Ohkuda K, Kageler W, Staub NC. Effect of heparin or fibrinogen depletion on lung fluid balance in sheep after emboli. J Appl Physiol 1979; 47:213-219.
56. Binder AS, Kageler W, Perel A, Flick MR, Staub NC. Effect of platelet depletion on lung vascular permeability after microemboli in sheep. J Appl Physiol 1980; 48:414-420.
57. Warren BA, Philp RB, lnwood MJ. The ultrastructural morphology of air embolism: Platelet adhesion to the interface and endothelial damage. Br J Exp Pathol 1973; 54:163-172.
58. Philp RB. A review of blood changes associated with compression-decompression: Relationship to decompression sickness. Undersea Biomed Res 1974; 1:117-150.
59. Nossum V, Koteng S, Brubakk AO. Endothelial damage by bubbles in the pulmonary artery of the pig. Undersea Hyperb Med 1999; 26:1-8.
60. Haller C, Sercombe R, Verrecchia C, Fritsch H, Seylaz J, Kuschinsky W. Effect of the muscarinic agonist carbachol on piai arteries in vivo after endothelial damage by air embolism. J Cereb Blood Flow Metab 1987: 7:605-611.
61. Anderson DK, Means ED. Iron-induced lipid peroxidation in spinal cord: Protection with mannitol and methylprednisolone. J Free Radic Biol Med 1985; 1:59-64.
62. Hardman JM, Beckman EL. Pathogenesis of central nervous system decompression sickness. Undersea Biomed Res 1990; 17(suppl):95-96.
63. 2 pressures between 0.12 and 2.5 atm abs, circulatory function, and N2 elimination. Undersea Biomed Res 1991; 18:279-292.
64. 2between a gas pocket and tissue in a hyperbaric environment. Respir Physiol 1968; 6:23-28.
65. Vann RD, Thalmann ED. Decompression physiology and practice. In: Bennett PB, Elliot DH, eds. The Physiology and Medicine of Diving. London: Saunders, 1993: 376-432.
66. Waligora JM, Horrigan D. Jr, Conkin J, Hadley AT III. Verification of an Altitude Decompression Sickness Prevention Protocol for Shuttle Operation Utilizing a 10.2 psi Pressure Stage. NASA Technical Memorandum 58259. Houston, TX: National Aeronautics and Space Administration, 1984.
67. Hempleman HV. History of decompression procedures. In: Bennett PB, Elliot DH, eds. The Physiology and Medicine of Diving. London: Saunders. 1993:342-375.
68. Erde A, Edmonds C. Decompression sickness: A clinical series. J Occup Med 1975; 17:324-328.
69. Brew SK. Kenny CT, Webb RK, Gorman DF. The outcome of 125 divers with dysbaric illness treated by recompression at HMNZS PHILOMEL. SPUMS J 1990; 20:226-230.
70. Bennett PB, Coggin R, Roby J. Control of HPNS in humans during rapid compression with trimix to 650 m (2131 ft). Undersea Biomed Res 1981; 8:85-100.
71. Piccard J. Aeroemphysema and the birth of bubbles. Proc Staff Meet Mayo Clin 1941; 16:700-704.
72. Bason R, Yacavone DW. Loss of cabin pressurization in U.S. Naval aircraft: 1969—90. Aviat Space Environ Med 1992; 63:341-345.
73. Neubauer JC, Dixon JP, Hemdon CM. Fatal pulmonary decompression sickness: A case report. Aviat Space Environ Med 1988; 59:1181-1184.
74. Dixon JP. Death from altitude-induced decompression sickness: Major pathophysiologic factors. In: Pilmanis AA, ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base. TX: Air Force Systems Command, 1992:97-105.
75. Fryer DI. Subatmospheric Decompression Sickness in Man. AGARDograph 125. Brussels: North Atlantic Treaty Organization, 1969:141-189.
76. Baumgartner N. Weien RW. Decompression sickness due to USAF altitude chamber exposure (1985-1987). In: Pilmanis AA, ed. Proceedings of the 1990 Hypo-baric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base. TX: Air Force Systems Command, 1992:363-376.
77. Weien RW. Altitude decompression sickness: The U.S. Army experience. In: Pilmanis AA, ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base, TX: Air Force Systems Command, 1992:379-383.
78. Harding RW. DCS experience outside North America. In: Pilmanis AA, ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base, TX: Air Force Systems Command, 1992:467-471.
79. Catron PW, Flynn ET. Jr., Yaffe L, et al. Morphological and physiological responses of the lungs of dogs to acute decompression. J Appl Physiol 1984; 57: 467-474.
80. Levin LL, Stewart GJ, Lynch PR, Bove AA. Blood and blood vessel wall changes induced by decompression sickness in dogs. J Appl Physiol 1981; 50:944-949.
81. Barnard EE, Hanson JM, Rowton-Lee MA. Morgan AG, Polak A, Tidy DR. Postdecompression shock due to extravasation of plasma. Br Med J 1966; 5506:154-155.
82. Wells CH, Bond TP, Guest MM, Barnhart CC. Rhéologie impairment of the microcirculation during decompression sickness. Microvasc Res 1971; 3:162-169.
83. Davis JC, Elliott DH. Treatment of decompression disorders. In: Bennett PB. Elliott DH, eds. The Physiology and Medicine of Diving. London: Bailliere Tindall. 1982: 475-476.
84. Butler BD, Katz J. Vascular pressures and passage of gas emboli through the pulmonary circulation. Undersea Biomed Res 1988; 15:203-209.
85. Butler BD, Hills BA. The lung as a filter for microbubbles. J Appl Physiol 1979; 47:537-543.
86. Butler BD, Hills BA. Transpulmonary passage of venous air emboli. J Appl Physiol 1985; 59:543-547.
87. Katz J, Letman BC, Butler BD. Effects of inhalation anaesthetics on filtration of venous gas emboli by the pulmonary vasculature. Br J Anaesth 1988; 61:200-205.
88. Vik A, Brubakk AO. Hennessy TR. Jenssen BM, Ekker M. Slordahl SA. Venous air embolism in swine: Transport of gas bubbles through the pulmonary circulation. J Appl Physiol 1990; 69:237-244.
89. Lynch PR, Brigham M, Tuma R, Wiedeman MP. Origin and time course of gas bubbles following rapid decompression in the hamster. Undersea Biomed Res 1985: 12:105-114.
90. Marquez J, Sladen A, Gendell H. Boehnke M, Mendelow H. Paradoxical cerebral air embolism without an intracardiac septal defect. Case report. J Neurosurg 1981: 55:997-1000.
91. Bedell EA, Berge KH, LosassoTJ. Paradoxic air embolism during venous air embolism: Transesophageal echocardiographic evidence of transpulmonary air passage [see comments]. Anesthesiology 1994; 80:947-950.
92. Tommasino C, Rizzardi R, Beretta L, Venturino M, Piccoli S, Cerebral ischemia after venous air embolism in the absence of intracardiac defects. J Neurosurg An-esthesiol 1996: 8:30-34.
93. Gottdiener JS, Papademetriou V, Notargiacomo A, Park WY, Cutler DJ. Incidence and cardiac effects of systemic venous air embolism. Echocardiographic evidence of arterial embolization via noncardiac shunt. Arch Intern Med 1988; 148:795-800.
94. Black M, Calvin J, Chan KL, Walley VM. Paradoxic air embolism in the absence of an intracardiac defect. Chest 1991; 99:754-755.
95. Pilmanis AA, Meissner FW, Olson RM. Left ventricular gas emboli in six cases of altitude-induced decompression sickness. Aviat Space Environ Med 1996; 67: 1092-1096.
96. Yahagi N, Furuya H. The effects of halothane and pentobarbital on the threshold of transpulmonary passage of venous air emboli in dogs. Anesthesiology 1987; 67: 905-909.
97. Butler BD, Leiman BC, Katz J. Arterial air embolism of venous origin in dogs: Effect of nitrous oxide in combination with halothane and pentobarbitone. Can J Anaesth 1987; 34:570-575.
98. Vik A, Jenssen BM, Brubakk AO. Effect of aminophylline on transpulmonary passage of venous air emboli in pigs. J Appl Physiol 1991; 71:1780-1786.
99. Butler BD, Conkin J, Luehr S. Pulmonary hemodynamics, extravascular lung water and residual gas bubbles following low dose venous gas embolism in dogs. Aviat Space Environ Med 1989; 60:1178-1182.
100. Butler BD, Luehr S, Katz J. Venous gas embolism: Time course of residual pulmonary intravascular bubbles. Undersea Biomed Res 1989; 16:21-29.
101. Mandelbaum I, King H. Pulmonary air embolism. Surg Forum 1963; 14:236-238.
102. Meltzer RS, Tickner EG, Popp RL. Why do the lungs clear ultrasonic contrast? Ultrasound Med Biol 1980; 6:263-269.
103. Verstappen FT, Bernards JA, Kreuzer F. Effects of pulmonary gas embolism on circulation and respiration in the doe. I. Effects on circulation. Pflueers Arch 1977; 368:89-96.
104. Verstappen FT, Bernards JA, Kreuzer F. Effects of pulmonary gas embolism on circulation and respiration in the dog. III. Excretion of venous gas bubbles by the lung. Pflugers Arch 1977; 370:67-70.
105. Sergysels R, Jasper N, Delaunois L, Chang HK, Martin RR. Effect of ventilation with different gas mixtures on experimental lung air embolism. Respir Physiol 1978; 34:329-343.
106. Hlastala MP, Robertson HT, Ross BK. Gas exchange abnormalities produced by venous gas emboli. Respir Physiol 1979; 36:1-17.
107. Ohkuda K, Nakahara K. Binder A, Staub NC. Venous air emboli in sheep: Reversible increase in lung microvascular permeability. J Appl Physiol 1981; 51:887-894.
108. Butler BD. Pulmonary effects of decompression stress in the rat. Undersea Biomed Res 1991; 18(suppl):74.
109. Spencer MP, Oyama Y. Pulmonary capacity for dissipation of venous gas emboli. Aerosp Med 1971; 42:822-827.
110. Levy SE, Stein M, Totten RS, Bruderman I, Wessler S, Robin ED. Ventilation-perfusion abnormalities in experimental pulmonary embolism. J Clin Invest 1965; 44:1699-1707.
111. Soloff LA, Rodman T, Acute pulmonary embolism. 1. Review. Am Heart J 1967; 74:710-724.
112. Neuman TS, Spragg RG, Wagner PD, Moser KM. Cardiopulmonary consequences of decompression stress. Respir Physiol 1980; 41:143-153.
113. Perkett EA, Brigham KL, Meyrick B. Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity. Am J Pathol 1988; 132:444-454.
114. Perkett EA, Brigham KL, Meyrick B. Granulocyte depletion attenuates sustained pulmonary hypertension and increased pulmonary vasoreactivity caused by continuous air embolization in sheep. Am Rev Respir Dis 1990; 141:456-465.
115. Bernard GR. Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Persistent generation of peptido leukotricnes in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:263-267.
116. Bonsignore MR, Rice TR, Dodek PM, Staub NC. Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep. Microcirc Endothel Lymphat 1986; 3:187-212.
117. Fukushima M, Kobayashi T. Effects of thromboxane synthase inhibition on air emboli lung injury in sheep. J App] Physiol 1986; 60:1828-1833.
118. Butler BD, Powell MR, Little T. Dose response levels of 11-dehydrothromboxane B2 (TxB2) and leukotriene E4 (LTE4) with venous air embolism (abstr). Undersea Biomed Res 1995; 22(suppl):40.
119. Butler BD, Little T. Effects of venous air embolism and decompression on thromboxane and leukotriene levels in dogs (abstr). Undersea Hyperb Med 1994; 21(suppl):21-22.
120. Butler BD, Little T, Doursout MF. Experimental decompression sickness: role of inflammatory mediators (abstr). FASEB J 1999; 13:A407.
121. Butler BD, Doursout MF, Little T. Plasma nitric oxide (NO) levels with venous air embolism and decompression (abstr). Undersea Hyperb Med 1999; 26(suppl):58.
122. Butler BD, Little T, Smolensky M. Circadian rhythm influences on decompression outcome in rats. In: Tovitov Y, ed. Biological Clocks Mechanisms and Application. Amsterdam: Elsevier, 1998:541-544.
123. Adomato DC, Gildenberg PL, Ferrario CM, Smart J, Frost EA. Pathophysiology of intravenous air embolism in dogs. Anesthesiology 1978; 49:120-127.
124. Vik A, Jenssen BM, Eftedal O, Brubakk AO, Relationship between venous bubbles and hemodynamic responses after decompression in pigs. Undersea Hyperb Med 1993; 20:233-248.
125. Brubakk AO, Flook V, Vik A. Gas bubbles and the lungs. In: Lundgren C. Miller JN, eds. The Lung at Depth. New York: Marcel Dekker, 1999:237-294.
126. Holt EP. Jr., Webb WR, Cook WA. Unal MO. Air embolism. Hemodynamics and therapy. Ann Thorac Surg 1966; 2:551-560.
127. Geissler HJ, Allen SJ. Mehlhom U. Davis KL, Morris WP, Butler BD. Effect of body repositioning after venous air embolism. An echocardiographic study Anesthesiology 1997; 86:710-717.
128. Bove AA, Hallenbeck JM, Elliott DH. Circulatory responses to venous air embolism and decompression sickness in dogs. Undersea Biomed Res 1974; 1: 207-220.
129. Powell MR, Spencer MP, von Ramm O, Ultrasonic surveilance of decompression. In: Bennett B, Elliot DH, eds. The Physiology and Medicine of Diving. London: Bailliere Tindall, 1982:404-434.
130. Gronert GA, Messick JM, Jr., Cucchiara RF, Michenfelder JD. Paradoxical air embolism from a patent foramen ovale. Anesthesiology 1979; 50:548-549.
131. Butler BD, Hills BA. Effect of excessive oxygen upon the capability of the lungs to filter gas emboli. In: Bachrach AJ, Matzen MM, eds. Underwater Physiology VII. Bethesda, MD: Undersea Medical Society, 1981:95-102.
132. Brubakk AO, Peterson R, Grip A, et al. Gas bubbles in the circulation of divers after ascending excursions from 300 to 250 msw. J Appl Physiol 1986; 60:45-51.
133. Stone DA, Godard J, Corretti MC. et al. Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131:158-161.
134. Di Tullio M, Sacco RL, Venketasubramanian N. Sherman D. Mohr JP. Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993; 24:1020-1024.
135. Job FP. Ringelstein EB. Grafen Y, et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994; 74:381-384.
136. Germonpre P, Dendale P, Unger P, Balestra C. Patent foramen ovale and decompression sickness in sports divers. J Appl Physiol 1998; 84:1622-1626.
137. Knauth M, Ries S, Pohimann S. et al. Cohort study of multiple brain lesions in sport divers: Role of a patent foramen ovale. Br Med J 1997: 314:701-705.
138. Clark JB, Hayes GB. Patent foramen ovale and type II altitude decompression sickness (abstr). Aviat Space Environ Med 1991; 62:445.
139. Gallagher KL. Hopkins EW, Clark JB, Hawley TA. U.S. Navy experience with type II decompression sickness and the association with patent foramen ovale (abstr). Aviat Space Environ Med 1996; 67:712.
140. Conkin J, Powell MR, Foster PP, Waligora JM. Information about venous gas emboli improves prediction of hypobaric decompression sickness. Aviat Space Environ Med 1998; 69:8-16.
141. Bendrick GA, Ainscough MJ, Pilmanis AA. Bisson RU. Prevalence of decompression sickness among U-2 pilots. Aviat Space Environ Med 1996; 67:199-206.
142. Weien RW, Baumgartner N. Altitude decompression sickness: Hyperbaric therapy results in 528 cases. Aviat Space Environ Med 1990; 61:833-836.
143. Garrett JL, Bradshaw P. The USAF chamber training flight profiles. In: Pilmanis A A. ed. Proceedings of the 1990 Hypobaric Decompression Sickness Workshop. AL-SR-1992-0005. Brooks Air Force Base, TX: Air Force Systems Command, 1992:346-359.
144. Robinson RR, Doursout MF, Chelly JE, Powell MR, Little TM, Butler BD. Cardiovascular deconditioning and venous air embolism in simulated microgravity in the rat. Aviat Space Environ Med 1996: 67:835-840.
145. Bason R, Yacavone D, Decompression sickness: U.S. Navy altitude chamber experience 1 October 1981 to 30 September 1988. Aviat Space Environ Med 1991; 62: 1180-1184.
146. Gray JS. The Effect of Exercise at Altitude on Aeroembolism in Cadets. Reports 156-1 and 169. Washington, DC: U.S. NRCC Comm Aviat Med, 1943.
147. Henry FM. The role of exercise in altitude pain. Am J Physiol 1946; 145:279-284.
148. Pilmanis AA, Olson RM, Fischer MD. Wiegman JF, Webb JT. Exercise-induced altitude decompression sickness. Aviat Space Environ Med 1999; 70:22-29.
149. Powell MR. Waligora JM, Norfleet W, Kumar KV. Project Argo—Gas Phase Formation in Simulated Microgravity. NASA technical memorandum 104762. Houston, TX: National Aeronautics and Space Administration, 1993.
150. Waligora JM, Pepper LJ. Physiological experience during Shuttle EVA. 25th International Conference on Environmental Systems. SAE Technical Paper Series 951592. Warrendale, PA: Society of Automotive Engineers. 1995:1-6.
151. Collins M. Carrying the Fire. New York: Ballantine, 1974:383.
152. Norfleet W. Analgesic use by astronauts during the peri-EVA period (abstr). Aviat Space Environ Med 1993; 64:423.
153. Boothby WM, Lovalace JR, Benson OO. High altitude and its effect on the human body. J Aerosp Soc Am 1940; 7:1.
154. Allen TH, Maio DA, Bancroft RW. Body fat, denitrogenation and decompression sickness in men exercising after abrupt exposure to altitude. Aerosp Med 1971; 42:518-524.
155. Kazakova RT, Poleschchuk IP. Checking effectiveness of prevention of high altitude decompression disorders by means of prebreathing in an oxygen environment (in Russian). Kosm Biol Med 1978; 2:28-31.
156. Waligora JM, Horrigan DJ, Jr., Conkin J. The effect of extended 0; prebreathing on altitude decompression sickness and venous gas bubbles. Aviat Space Environ Med 1987; 58:A110-A112.
157. Webb JT, Fischer MD, Heaps CL, Pilmanis AA, Exercise-enhanced preoxygenation increases protection from decompression sickness. Aviat Space Environ Med 1996; 67:618-624.
158. Gemhardt ML, Conkin J, Foster PP. et al. Design of a 2-hour prebreathe protocol for space walks from the International Space Station (abstr). Avial Space Environ Med 2000; 71:277.
159. Powell MR, Waligora JM. Kumar KV, Loftin KC. Hypobaric decompression in simulated null gravity: a model using chair-rest adynamia (abstr). Undersea Hyperb Med 1995; 22(suppl):67.
160. Conkin J. Edwards BF, Waligora JM, Stanford J. Jr, Gilbert JH. III. Horrigan D Jr. Updating Empirical Models that Predict the Incidence of Altitude Decompression Sickness and Venous Gas Emboli for Shuttle and Space Station Extravehicular Operations. NASA Technical Memorandum 100456 Update. Houston, TX: National Aeronautic and Space Administration, 1990.
161. Waligora JM, Powell MR, Norfleet W. The abaroferic hypothesis: A mechanism for reduction in risk of decompression sickness in microgravity (abstr). Aviat Space Environ Med 1993; 64:421.
162. Vann RD, Gerth WA, Leatherman NE, Exercise and decompression sickness. In: Vann RD. ed. The Physiological Basis of Decompression. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1989: 119-137.
163. Waligora JM, Conkin J, Foster PP. et al. Operational implementation of a 2-hour prebreathe protocol for International Space Station (abstr). Aviat Space Environ Med 2000: 71:278.
164. Butler BD, Vann RD, Nishi RY, et al. Human trials of a 2-hour prebreathe protocol for extravehicular activity (abstr). Aviat Space Environ Med 2000; 71:278.
165. United States Navy. U.S. Navy Diving Manual. NAVSEA 0994-LP-9010. Washington, DC: Naval Sea Systems Command, 1993.
166. Butler FK, Jr., Knafelc ME. Screening for oxygen intolerance in U.S. Navy divers. Undersea Biomed Res 1986; 13:91-98.
167. Clark JM. Oxygen toxicity. In: Bennett PB, Elliot DH, eds. The Physiology and Medicine of Diving. London: Saunders, 1993:121-169.
168. Parker JC, Taylor AE. Oxygen toxicity. In: Lundgren C. Miller JN, eds. The Lung at Depth. New York: Marcel Dekker, 1999:165-209.
169. Flynn ET, Bayne CG, Diving Medical Officer Student Guide. Course A-6A-0010. Washington, DC: U.S. Government Printing Office, 1977:321-326.
170. Omhagen H, Hamilton RW. Oxygen Enriched Air—“Nitrox”—in Surface Oriented Diving. Stockholm: National Defence Research Establishment, 1989.
171. Kumar VK, Billica RD, Waligora JM. Utility of Doppler-detectable microbubbles in the diagnosis and treatment of decompression sickness. Aviat Space Environ Med 1997; 68:151-158.
172. Karman N, Raychaudhuri A. Pilmanis AA. A loglogistic model for altitude decompression sickness. Aviat Space Environ Med 1998; 69:965-970.
173. Ryles MT, Pilmanis AA. The initial signs and symptoms of altitude decompression sickness. Aviat Space Environ Med 19%; 67:983-989.
174. Heimbach RD, Sheffield PJ. Decompression sickness and pulmonary overpressure in accidents. In: DeHart RL, ed. Fundamentals of Aerospace Medicine. Baltimore: Williams & Wilkins, 1996:131-161.
175. Kimbrell PN. Treatment of altitude decompression sickness. In: Moon RE, Sheffield PJ, eds. Treatment of Decompression Illness. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996:43-51.
176. Krause KM, Pilmanis A A. The effectiveness of ground level oxygen treatment for altitude decompression sickness in human research subjects. Aviat Space Environ Med 2000; 71:115-118.
177. Rudge FW. The role of ground level oxygen in the treatment of altitude chamber decompression sickness. Aviat Space Environ Med 1992; 63:1102-1105.
178. Demboski JT, Pilmanis AA. Effectiveness of ground level oxygen as therapy for pain-only altitude decompression sickness (abstr). Aviat Space Environ Med 1994; 65:454.
179. Sukoff MH, Ragatz RE. Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery 1982; 10:29-38.
180. Miller JD, Ledingham IM, Jennett WB. Effects of hyperbaric oxygen on intracranial pressure and cerebral blood flow in experimental cerebral oedema. J Neurol Neurosurg Psychiat 1970; 33:745-755.
181. Zamboni WA. Roth AC, Russell RC, Kucan J. The effect of hyperbaric oxygen treatment on the microcirculation of ischemic skeletal muscle. Undersea Biomed Res 1990; 17(suppl):26.
182. Zamboni WA, Roth AC, Russell RC, Nemiroff PM, Casas L, Smoot EC. The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg 1989; 5:343-347; discussion 349-350.
183. Workman RD. Treatment of bends with oxygen at high pressure. Aerosp Med 1968; 39:1076-1083.
184. Leitch DR, Hallenbeck JM. Oxygen in the treatment of spinal cord decompression sickness. Undersea Biomed Res 1985; 12:269-289.
185. Sykes JJ, Hallenbeck JM, Leitch DR. Spinal cord decompression sickness: A comparison of recompression therapies in an animal model. Aviat Space Environ Med 1986; 57:561-568.
186. United States Navy. U.S. Navy Diving Manual. NAVSEA 0994-LP-9010. Washington, DC: Naval Sea Systems Command, 1993:45.
187. Drummond JC, Moore SS. The influence of dextrose administration on neurologic outcome after temporary spinal cord ischemia in the rabbit. Anesthesiology 1989; 70:64-70.
188. Moon RE, Sheffield PJ. Consensus statement. In: Moon RE, Sheffield PJ. eds. Treatment of Decompression Illness. Kensington, MD: Undersea and Hyperbaric Medical Society, 1996:417-426.
189. Cogar WB. Intravenous lidocaine as adjunctive therapy in the treatment of decompression illness. Ann Emerg Med 1997; 29:284-286.
190. Drewry A, Gorman DF. Lidocaine as an adjunct to hyperbaric therapy in decompression illness: A case report. Undersea Biomed Res 1992; 19:187-190.
191. Broome JR, Dick EJ, Jr. Neurological decompression illness in swine. Aviat Space Environ Med 1996; 67:207-213.
192. Kizer KW. Corticosteroids in treatment of serious decompression sickness. Ann Emerg Med 1981: 10:485-488.
193. Francis TJR, Dutka AJ, Clark JB. An evaluation of dexamethasone in the treatment of acute experimental spinal decompression sickness. In: Bove AA, Bachrach AJ, Greenbaum LJ, eds. Proceedings of 9th International Symposium on Underwater and Hyperbaric Physiology. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1987:999-1013.
194. Lynch PR, Krasner LJ, Vinciquerra T, Shaffer TH, Effects of intravenous perfluo-rocarbon and oxygen breathing on acute decompression sickness in the hamster. Undersea Biomed Res 1989; 16:275-281.
195. Spiess BD, McCarthy RJ, Turnan KJ, Woronowicz AW, Tool KA, Ivankovich AD. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). Undersea Biomed Res 1988; 15:31-37.
196. Catron PW, Flynn ET, Jr. Adjuvant drug therapy for decompression sickness: A review. Undersea Biomed Res 1982; 9:161-174.
197. Philip RB, Bennett PB, Andersen JC, et al. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers. Undersea Biomed Res 1979; 6:127-146.
198. Powell MR, Norfleet WT, Kumar KV, Butler BD. Patent foramen ovale and hypo-baric decompression. Aviat Space Environ Med 1995; 66:273-275.
199. Rudge FW, Shafer MR. The effect of delay on treatment outcome in altitude-induced decompression sickness. Aviat Space Environ Med 1991; 62:687-690.
200. National Aeronautics and Space Administration. SSP Flight Data File. JSC 48092. Houston, TX: National Aeronautics and Space Administration, 1997:2-13.
201. Butler BD, Kurusz M. Embolic events. In: Gravlee GL, Davis RF, Kurusz M, Utley JR, eds. Cardiopulmonary Bypass: Principles and Practice. Philadelphia: Lippin-cott. Williams & Wilkins, 2000:320-341.
202. Norfleet W. Options and plans for treatment of decompression sickness aboard Space Station Freedom. In: Pilmanis AA, ed. Proceedings of the 1990 hypobaric decompression sickness workshop. AL-SR-1992-005. Brooks Air Force Base. TX: Air Force Systems Command. 1992: 315-326.
203. Hills BA. Decompression Sickness. Vol. 1. Chichester: Wiley, 1977.